CD147 and cyclophilin A: a promising potential targeted therapy for COVID-19 and associated cancer progression and chemo-resistance
Abstract Coronavirus disease-2019 (COVID-19), as a worldwide serious issue has been shown to lead to progression and poor outcomes in cancer patients. The underlying mechanisms for SARS-CoV-2 infection’s adverse effects on cancer patients have not been fully understood. We hypothesized that CD147 an...
Main Authors: | Maryam Bakhtiyari, Ayda Haji Aghasi, Sara Banihashemi, Arian Abbassioun, Chanour Tavakol, Hamidreza Zalpoor |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | Infectious Agents and Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13027-023-00501-2 |
Similar Items
-
Cyclophilin A/CD147 Interaction: A Promising Target for Anticancer Therapy
by: Jang Mi Han, et al.
Published: (2022-08-01) -
Extracellular cyclophilins A and C induce dysfunction of pancreatic microendothelial cells
by: Rebeca Alvariño, et al.
Published: (2022-10-01) -
CD147-Cyclophilin a Interactions Promote Proliferation and Survival of Cutaneous T-Cell Lymphoma
by: Minami Sakamoto, et al.
Published: (2021-07-01) -
The interaction between Cyclophilin A and CD147 and its clinical significance in periodontal diseases
by: YANG Ting, et al.
Published: (2021-03-01) -
Spongionella secondary metabolites, promising modulators of immune response through CD147 receptor modulation
by: Jon Andoni Sánchez, et al.
Published: (2016-10-01)